Drug-releasing Biopolymeric Structures Manufactured via Stereolithography
No Thumbnail Available
Access rights
openAccess
URL
Journal Title
Journal ISSN
Volume Title
A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä
This publication is imported from Aalto University research portal.
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Date
2019-01-10
Major/Subject
Mcode
Degree programme
Language
en
Pages
Series
BIOMEDICAL PHYSICS & ENGINEERING EXPRESS
Abstract
Additive manufacturing (AM) techniques, such as stereolithography (SLA), enable the preparation of designed complex structures. AM has gained interest especially in the tissue engineering field due to the possibility to manufacture patient specific implants. However, AM could be useful also in controlled drug release applications, since the size and shape of the device, pore architecture and surface to volume ratio can be accurately designed. In this study, SLA was used to prepare polycaprolactone scaffold structures containing the model drug lidocaine. The release of lidocaine was studied and the influence of porosity and surface to volume ratio of structures to the drug release was analyzed. Porous samples released lidocaine faster compared to solid ones, whereas the degree of porosity and surface to volume ratio did not have a clear effect on the drug release profile.Description
Keywords
Other note
Citation
Asikainen, S, van Bochove, B & Seppälä, J 2019, ' Drug-releasing Biopolymeric Structures Manufactured via Stereolithography ', BIOMEDICAL PHYSICS & ENGINEERING EXPRESS . https://doi.org/10.1088/2057-1976/aaf0e